Overview
Publication Venue For
Laquinimod has no effects on brain volume or cellular CNS composition in the F1 3xTg-AD/C3H mouse model of Alzheimer's disease.
309:100-110.
2017
T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis.
297:1-8.
2016
Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).
274:14-19.
2014
IFNγ inhibits Th17 differentiation and function via Tbet-dependent and Tbet-independent mechanisms.
267:20-27.
2014
Localisation of citrullinated proteins in normal appearing white matter and lesions in the central nervous system in multiple sclerosis.
273:85-95.
2014
IL-21 optimizes T cell and humoral responses in the central nervous system during viral encephalitis.
263:43-54.
2013
Immunological functioning in Alzheimer's disease: Differential effects of relative left versus right temporoparietal dysfunction.
263:128-132.
2013
The complement anaphylatoxin receptors are not required for the development of experimental autoimmune uveitis.
264:127-129.
2013
Sex hormone-dependent attenuation of EAE in a transgenic mouse with astrocytic expression of the RNA regulator HuR.
246:34-37.
2012
Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS.
243:81-88.
2012
Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis.
223:92-99.
2010
Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis.
220:99-103.
2010
Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.
219:54-63.
2010
Erratum to "The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial" [J. Neuroimmunol. 201-202(2008)80-84] (DOI:10.1016/j.jneuroim.2008.05.031).
217:103.
2009
Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen.
217:51-54.
2009
Deletion of the G2A receptor fails to attenuate experimental autoimmune encephalomyelitis.
207:18-23.
2009
Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis.
206:22-27.
2009
The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial.
201-202:80-84.
2008
Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats.
195:47-59.
2008
Identification of pyruvate kinase as an antigen associated with Tourette syndrome.
181:165-176.
2006
Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation.
179:132-144.
2006
PSGL-1 is not required for development of experimental autoimmune encephalomyelitis.
166:193-196.
2005
Regulation of CD8+ cytolytic T lymphocyte differentiation by a cholinergic pathway.
164:66-75.
2005
CRH stimulates POMC activity and corticosterone production in dermal fibroblasts.
162:97-102.
2005
Neuroimaging in human immunodeficiency virus infection.
157:153-162.
2004
An IgM anti-MBP Ab in a case of Waldenstrom's macroglobulinemia with polyneuropathy expressing an idiotype reactive with an MBP epitope immunodominant in MS and EAE.
113:163-169.
2001
Highly related immunoglobulin light chain sequences in different multiple sclerosis patients.
100:98-101.
1999
Adhesion molecule expression and regulation on cells of the central nervous system.
98:77-88.
1999
Interleukin-6 expression and regulation in astrocytes.
100:124-139.
1999
HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues.
92:152-159.
1998
Transcriptional regulation of intercellular adhesion molecule-1 in astrocytes involves NF-κB and C/EBP isoforms.
92:196-207.
1998
Kinase inhibitors abrogate IFN-γ-induced class II transactivator and class II MHC gene expression in astroglioma cell lines.
85:174-185.
1998
Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes.
78:47-56.
1997
Induction of RANTES expression by astrocytes and astrocytoma cell lines.
71:207-214.
1996
Preferential association of Vλx light chains with γ2a heavy chains in naturally occurring human myelin basic protein reactive antibodies.
70:15-20.
1996
The kinetics of ACTH expression in rat leukocyte subpopulations.
63:103-112.
1995
Arecoline a muscarinic cholinergic agent conditions central pathways that modulate natural killer cell activity.
59:57-63.
1995
Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-α, interleukin-1β, and interferon-γ in astrocytes.
51:209-220.
1994
Role of arcuate nucleus of the hypothalamus in the acquisition of association memory between the CS and US.
50:109-114.
1994
Fine-specificity differences in the recognition of an encephalitogenic peptide by T helper 1 and 2 cells.
48:221-226.
1993
Interleukin-6 production by astrocytes: Induction by the neurotransmitter norepinephrine.
45:137-145.
1993
The identity of the unconditioned stimulus to the central nervous system is interferon-β.
45:75-81.
1993
The structure of a myelin basic protein-associated idiotope.
46:235-243.
1993
Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-κ B-like nuclear protein.
39:231-242.
1992
Immune processing of proteolipid protein by subsets of antigen-presenting spleen cells.
38:139-146.
1992
Interferon-gamma regulation of C3 gene expression in human astroglioma cells.
38:275-282.
1992
Interleukin-1β induction of tumor necrosis factor-alpha gene expression in human astroglioma cells.
36:179-191.
1992
Corticotropin-releasing factor upregulates expression of two truncated pro-opiomelanocortin transcripts in murine lymphocytes.
31:51-58.
1991
Expression of immunoreactive growth hormone in leukocytes in vivo.
33:43-54.
1991
Functional assessment and partial characterization of [3H](+)-pentazocine binding sites on cells of the immune system.
35:153-166.
1991
Corticotropin-releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway.
28:53-61.
1990
Immunomodulatory characteristics of a novel antiproliferative protein, suppressin.
30:179-187.
1990
Immunoreactive growth hormone-releasing hormone in rat leukocytes.
29:1-13.
1990
Induction and regulation of class II major histocompatibility complex mRNA expression in astrocytes by interferon-γ and tumor necrosis factor-α.
30:189-200.
1990
Induction and regulation of interleukin-6 gene expression in rat astrocytes.
30:201-212.
1990
The development and characterization of encephalitogenic cloned T cells specific for myelin proteolipid protein.
26:139-145.
1990
Tumor necrosis factor production and receptor expression by a human malignant glioma cell line, D54-MG.
30:1-13.
1990
Interleukin-2 induction of ACTH secretion: presence of an interleukin-2 receptor α-chain-like molecule on pituitary cells.
21:249-254.
1989
Monoclonal idiotypic and anti-idiotypic antibodies produced by immunization with peptides specified by a region of human myelin basic protein mRNA and its complement.
22:157-166.
1989
The adoptive transfer of chronic relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein.
21:183-191.
1989
Tumor necrosis factor-α enhances interferon-γ-mediated class II antigen expression on astrocytes.
25:209-219.
1989
Response of human glioblastoma cells to recombinant interleukin-2.
17:301-314.
1988
An antibody to a peptide specified by an RNA that is complementary to γ-endorphin mRNA recognizes an opiate receptor.
12:329-337.
1986
Neuroendocrine peptide hormones and their receptors in the immune system. production, processing and action.
10:31-40.
1985
